现代胃食管反流病诊断更新:里昂共识2.0
里昂共识2.0由国际核心与工作组制定,基于原始共识发布后的研究更新胃食管反流病诊断标准。新共识提出「可干预胃食管反流病」定义,将洛杉矶分级B级食管炎列为确诊证据,并描述无线pH监测指标及难治性胃食管反流病的诊断参数。
要点
- 里昂共识2.0将洛杉矶分级B级食管炎确立为胃食管反流病的确诊证据。
- 未证实胃食管反流病患者采用延长无线pH监测或停用抑酸药后导管pH监测。
- 已证实胃食管反流病且症状持续者,在优化抑酸治疗期间行pH-阻抗监测。
核心结论
- 里昂共识2.0提供可干预胃食管反流病的现代定义,即食管检测证据支持对症状患者调整、升级或个体化胃食管反流病管理。
- 根据症状与反流事件关联可能性高低进行描述,并区分未证实与已证实胃食管反流病以确定诊断策略和检测选项。
研究设计与样本
- 国际核心与工作组汇集,评估原始里昂共识发布后的研究,并对协作制定的更新标准声明进行投票。
主要发现
- 主要变化包括将洛杉矶分级B级食管炎确立为胃食管反流病的确诊证据。
- 描述了用于延长无线pH监测的指标和阈值。
- 纳入了在已证实胃食管反流病患者于抑酸治疗期间检测时有助于诊断难治性胃食管反流病的参数。
- 在可干预胃食管反流病诊断中表现不佳的标准已被淘汰。
关键数值与推荐
- 未证实胃食管反流病患者使用延长无线pH监测或停用抑酸药后导管pH或pH监测进行研究。
- 已证实胃食管反流病且有持续症状的患者,在优化抑酸治疗期间使用pH-阻抗监测进行评估。
- 洛杉矶分级B级食管炎被确立为胃食管反流病的确诊证据。
临床怎么用
- 对无既往胃食管反流病证据(未证实胃食管反流病)的患者,采用延长无线pH监测或停用抑酸药后的导管pH或pH监测。
- 对已有确诊胃食管反流病证据(已证实胃食管反流病)且症状持续的患者,在优化抑酸治疗期间行pH-阻抗监测。
- 将检测和管理个体化至每位患者的独特表现以优化胃食管反流病诊断和管理。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Lyon Consensus provides conclusive criteria for and against the diagnosis of gastro-oesophageal reflux disease (GERD), and adjunctive metrics that consolidate or refute GERD diagnosis when primary criteria are borderline or inconclusive. An international core and working group was assembled to evaluate research since publication of the original Lyon Consensus, and to vote on statements collaboratively developed to update criteria. The Lyon Consensus 2.0 provides a modern definition of actionable GERD, where evidence from oesophageal testing supports revising, escalating or personalising GERD management for the symptomatic patient. Symptoms that have a high versus low likelihood of relationship to reflux episodes are described. Unproven versus proven GERD define diagnostic strategies and testing options. Patients with no prior GERD evidence (unproven GERD) are studied using prolonged wireless pH monitoring or catheter-based pH or pH-monitoring off antisecretory medication, while patients with conclusive GERD evidence (proven GERD) and persisting symptoms are evaluated using pH-impedance monitoring while on optimised antisecretory therapy. The major changes from the original Lyon Consensus criteria include establishment of Los Angeles grade B oesophagitis as conclusive GERD evidence, description of metrics and thresholds to be used with prolonged wireless pH monitoring, and inclusion of parameters useful in diagnosis of refractory GERD when testing is performed on antisecretory therapy in proven GERD. Criteria that have not performed well in the diagnosis of actionable GERD have been retired. Personalisation of investigation and management to each patient's unique presentation will optimise GERD diagnosis and management.
引用
- Gyawali CP, Yadlapati R, Fass R, et al. Updates to the modern diagnosis of GERD: Lyon consensus 2.0. Gut. 2024. PMID: 37734911. doi:10.1136/gutjnl-2023-330616
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。